CATALYST PHARMACEUTICALS, INC.·4

Dec 29, 5:00 PM ET

GRANDE ALICIA 4

4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 29, 2023

Insider Transaction Report

Form 4
Period: 2023-12-27
GRANDE ALICIA
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock, par value $0.001 per share

    2023-12-273,41055,813 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-12-278,6661,187,168 total
    Common Stock (8,666 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.001 per share

    2023-12-27+8,66659,223 total
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
  • [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
  • [F3]Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
  • [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 27, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4 FOR 12-27-2023